Yuriko Nagata
Overview
Explore the profile of Yuriko Nagata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tochinai R, Komatsu K, Murakami J, Nagata Y, Ando M, Hata C, et al.
J Toxicol Pathol
. 2018 Nov;
31(4):307-313.
PMID: 30393435
Cardiotoxicity is a concern in the development of microtubule-disassembling agents (MDAs) as vascular-disrupting agents of tumors. This study investigated cardiotoxicity in rats induced by a single-dose of combretastatin A4 disodium...
2.
Nagara Y, Takada T, Nagata Y, Kado S, Kushiro A
PLoS One
. 2017 Apr;
12(4):e0175497.
PMID: 28394924
Each species of intestinal bacteria requires a nutritional source to maintain its population in the intestine. Dietary factors are considered to be major nutrients; however, evidence directly explaining the in...
3.
Tochinai R, Nagata Y, Ando M, Hata C, Suzuki T, Asakawa N, et al.
J Toxicol Pathol
. 2016 Aug;
29(3):163-71.
PMID: 27559241
Histopathological and electrocardiographic features of myocardial lesions induced by combretastatin A4 disodium phosphate (CA4DP) were evaluated, and the relation between myocardial lesions and vascular changes and the direct toxic effect...
4.
Tochinai R, Suzuki K, Nagata Y, Ando M, Hata C, Komatsu K, et al.
J Toxicol Pathol
. 2014 Nov;
27(3-4):223-30.
PMID: 25378807
The microtubule inhibitor colchicine is cardiotoxic and is suggested to impair impulse formation and conduction. However, little is known about the electrocardiographic (ECG) changes induced by colchicine in experimental animals...
5.
Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, et al.
Clin Exp Pharmacol Physiol
. 2013 Apr;
40(7):422-30.
PMID: 23611112
The aim of the present study was to establish a progressive steatohepatitis mouse model because few reported animal models of non-alcoholic steatohepatitis (NASH) show the progression from fatty liver to...
6.
Tochinai R, Ando M, Suzuki T, Suzuki K, Nagata Y, Hata C, et al.
Exp Toxicol Pathol
. 2012 Nov;
65(6):737-43.
PMID: 23131582
Microtubule disassembling agents (MDAs) such as colchicine (COL) and vincristine sulfate (VCR) are known to be cardiotoxic. However, few attempts have been made to histopathologically examine cardiac lesions induced by...
7.
Ando M, Kado S, Suzuki T, Yamamoto R, Nagata Y, Hata C, et al.
J Toxicol Pathol
. 2012 Feb;
24(4):251-5.
PMID: 22319239
A subcutaneous tumor was found in the right abdomen of a 16-week-old male TCRβ and p53 double-knockout mouse. The tumor had indistinct borders with the surrounding tissue. The cut surface...
8.
Suzuki T, Kado S, Ando M, Nagata Y, Iwata S, Kobayashi T, et al.
J Toxicol Pathol
. 2012 Jan;
22(1):83-7.
PMID: 22271980
Cardiac hypertrophy was observed in a 9-week-old Crl:CD(SD) rat that died unexpectedly. The animal was allocated to the control group of a toxicity study, and no abnormalities in its general...